| scholarly article | Q13442814 |
| P2093 | author name string | Bum-Joon Park | |
| Nam-Chul Ha | |||
| Su-Jin Lee | |||
| Sun-Hye Lee | |||
| Yongbin Xu | |||
| Ho Sung Kang | |||
| Yeon Sang Jung | |||
| P2860 | cites work | Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways | Q44508741 |
| Oncogene-induced senescence as an initial barrier in lymphoma development | Q46634165 | ||
| Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. | Q47745236 | ||
| AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. | Q53343862 | ||
| MDM2 gene amplification in metastatic osteosarcoma | Q70521330 | ||
| Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas | Q72657594 | ||
| p53 Mutation and MDM2 amplification in human soft tissue sarcomas | Q72968853 | ||
| Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas | Q73784542 | ||
| Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress | Q24301523 | ||
| Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition | Q24305416 | ||
| Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a | Q24324559 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status | Q28143274 | ||
| The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells | Q28143877 | ||
| A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter | Q28190014 | ||
| Targeting RAS signalling pathways in cancer therapy | Q28201363 | ||
| Flavonols and pancreatic cancer risk: the multiethnic cohort study | Q28240121 | ||
| Divorcing ARF and p53: an unsettled case | Q28258356 | ||
| Mutant KRAS in the initiation of pancreatic cancer | Q28272767 | ||
| The transcriptional repressor Snail promotes mammary tumor recurrence | Q28272823 | ||
| The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR | Q28512723 | ||
| The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression | Q28595042 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas | Q29616243 | ||
| Restoration of p53 function leads to tumour regression in vivo | Q29618727 | ||
| p53 ubiquitination: Mdm2 and beyond | Q29619502 | ||
| Nucleolar Arf sequesters Mdm2 and activates p53 | Q29620244 | ||
| A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence | Q30699339 | ||
| The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 | ||
| Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation | Q34688909 | ||
| Ras signalling and apoptosis | Q34746668 | ||
| Snail in the frame of malignant tumor recurrence | Q35605788 | ||
| Oncogene-induced senescence pathways weave an intricate tapestry | Q36718786 | ||
| ATM and ATR: components of an integrated circuit | Q36741134 | ||
| A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin | Q38797735 | ||
| p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo | Q39676073 | ||
| Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. | Q40432782 | ||
| Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells | Q40520938 | ||
| Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context | Q40637553 | ||
| Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. | Q40845331 | ||
| Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells | Q44095249 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 22-31, 6p following 31 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function | |
| P478 | volume | 11 |
| Q40291299 | A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment |
| Q35671176 | Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas |
| Q38934098 | Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease? |
| Q33597685 | Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells |
| Q34074238 | Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs |
| Q58716411 | Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes |
| Q24628746 | Dinosaurs and ancient civilizations: reflections on the treatment of cancer |
| Q39562119 | Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease |
| Q40719959 | Domain analysis of the Nematostella vectensis SNAIL ortholog reveals unique nucleolar localization that depends on the zinc-finger domains |
| Q41438730 | Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths |
| Q36556357 | Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions |
| Q38718360 | Evidence of a prion-like transmission of p53 amyloid in Saccharomyces cerevisiae. |
| Q37589163 | Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system |
| Q35131817 | Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 |
| Q45405767 | Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma. |
| Q36087231 | KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation |
| Q37764054 | Major heat shock protein Hsp72 controls oncogene-induced senescence |
| Q64242213 | MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer |
| Q30374671 | Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer. |
| Q35832918 | NF2 blocks Snail-mediated p53 suppression in mesothelioma. |
| Q43006124 | New functions for the Snail family of transcription factors: Two-faced proteins |
| Q34086677 | Notch1 binds and induces degradation of Snail in hepatocellular carcinoma |
| Q34294188 | Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression |
| Q35657127 | Novel tumor suppressive function of Smad4 in serum starvation-induced cell death through PAK1-PUMA pathway |
| Q38215948 | Oncogenic roles of EMT-inducing transcription factors |
| Q54658888 | Polycomb group proteins: New targets of anti-cancer therapy. |
| Q28247699 | Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation |
| Q34606299 | Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells |
| Q28539044 | Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines |
| Q43122590 | Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail. |
| Q26752554 | Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks |
| Q50066565 | Silencing the Snail-dependent RNA splice regulator ESRP1 drives malignant transformation of human pulmonary epithelial cells |
| Q34362985 | Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells |
| Q49217039 | Snail1 transcription factor controls telomere transcription and integrity |
| Q38736464 | Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer |
| Q92376522 | Snail1: A Transcriptional Factor Controlled at Multiple Levels |
| Q37360050 | Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25. |
| Q89453867 | The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells |
| Q37478602 | The War on Cancer rages on. |
| Q35669733 | The interconnectedness of cancer cell signaling |
| Q37189626 | The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition |
| Q28385017 | UVB irradiation regulates ERK1/2- and p53-dependent thrombomodulin expression in human keratinocytes |
| Q89527591 | p53 controls the switch between autophagy and apoptosis through regulation of PLSCR1 in sodium selenite-treated leukemia cells |
| Q24306453 | p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma |
| Q51734453 | p53, secreted by K-Ras-Snail pathway, is endocytosed by K-Ras-mutated cells; implication of target-specific drug delivery and early diagnostic marker. |
Search more.